Robert Meyer
Directeur/Membre du Conseil chez CHIMERIX, INC.
Fortune : 33 990 $ au 31/05/2024
Profil
Robert James Meyer is currently an Independent Director at Chimerix, Inc., an Associate Professor-Public Health Sciences at the University of Virginia, and a Principal-Drug & Biological Products at Greenleaf Health Inc. Previously, he served as an Independent Director at Translate Bio, Inc. from 2019 to 2021.
He also held positions at the US Food & Drug Administration as the Director-Drug Evaluation & Research from 1999 to 2007, and at the Center for Drug Evaluation & Research as the Director-Office Drug Evaluation II from 1994 to 2007.
Additionally, he was the Director of the Virginia Center For Translational & Regulatory Sciences from 2013 to 2017, and a Director at Correvio Pharma Corp.
from 2015 to 2020.
He worked at Merck & Co., Inc. and Merck Research Laboratories Massachusetts LLC as the VP, Head-Global Regulatory Strategy & Policy from 2007 to 2013.
Furthermore, he served as a Trustee at The United States Pharmacopeia from 2015 to 2020.
Dr. Meyer obtained his undergraduate degree from Lehigh University in 1980 and his doctorate degree from The University of Connecticut School of Medicine in 1988.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CHIMERIX, INC.
0,04% | 31/03/2024 | 35 150 ( 0,04% ) | 33 990 $ | 31/05/2024 |
Postes actifs de Robert Meyer
| Sociétés | Poste | Début |
|---|---|---|
| CHIMERIX, INC. | Directeur/Membre du Conseil | 28/03/2018 |
Greenleaf Health Inc.
 Greenleaf Health Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kinsale Holdings, Inc., Greenleaf Health Inc. is a leading FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. The company is based in Washington. Greenleaf is guided by experts with a combined total of more than 300 years of FDA experience, including former leaders throughout the agency. The American company was founded in 2007 by Patrick Ronan. Greenleaf Health was acquired by Kinsale Holdings, Inc. on April 19, 2021. | Corporate Officer/Principal | 01/01/2018 |
| University of Virginia | Corporate Officer/Principal | - |
Anciens postes connus de Robert Meyer
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSLATE BIO, INC. | Directeur/Membre du Conseil | 14/09/2021 |
The United States Pharmacopeia
 The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Directeur/Membre du Conseil | 01/06/2020 |
| CORREVIO PHARMA CORP. | Directeur/Membre du Conseil | 01/01/2020 |
| Virginia Center For Translational & Regulatory Sciences | Directeur/Membre du Conseil | 01/12/2017 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2013 |
Formation de Robert Meyer
| Lehigh University | Undergraduate Degree |
| The University of Connecticut School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| CHIMERIX, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
| Center for Drug Evaluation & Research | Government |
The United States Pharmacopeia
The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Health Technology |
Greenleaf Health Inc.
Greenleaf Health Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kinsale Holdings, Inc., Greenleaf Health Inc. is a leading FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. The company is based in Washington. Greenleaf is guided by experts with a combined total of more than 300 years of FDA experience, including former leaders throughout the agency. The American company was founded in 2007 by Patrick Ronan. Greenleaf Health was acquired by Kinsale Holdings, Inc. on April 19, 2021. | Commercial Services |
| Virginia Center For Translational & Regulatory Sciences |
